Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05684887
Other study ID # EG0284
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 18, 2022
Est. completion date July 30, 2023

Study information

Verified date December 2023
Source Elizabeth Glaser Pediatric AIDS Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

According to the WHO, contact tracing - along with robust testing, isolation, and care of cases is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19. Contact tracing, however, has a number of challenges. These include incomplete identification of contacts, inefficiencies in paper-based reporting systems, complex data management requirements, and delays in the identification of contacts and testing of contacts. In many settings, contact tracing has proven to be too resource-intensive to implement at scale, especially with higher levels of community transmission, highlighting the need for more efficient contact tracing approaches. Digital tools afford the possibility of strengthening contact tracing for COVID-19, in a more efficient way. However, there is limited evidence of the effectiveness and impact of these tools in the COVID-19 response, including contact tracing. This study proposes to compare the cascade of care between two strategies for COVID-19 contact tracing of SARS-CoV-2 infected index patients in Cameroon. In one strategy (intervention), the health facilities and health district testing units will implement contact tracing using a digital tool developed to support the tracing and testing of contacts (addition of a digital contact tracing module to the main platform for COVID-19 testing in Cameroon (Mamal Pro app)). This strategy will be compared to the standard contact tracing process (control), based on the current routine approach (use of the Mamal Pro application without the digital contact tracing module).


Description:

The study's general objective is to assess the effectiveness, feasibility, acceptability, and cost associated with the addition of a Mamal Pro digital contact tracing module to the Mamal Pro app in improving COVID-19 contact tracing and testing in Littoral, Cameroon. Specific objectives are: 1. Primary objective: To determine the effectiveness of the use of a Mamal Pro digital contact tracing module added to the Mamal Pro app in improving COVID-19 contact tracing and testing compared to the SOC as measured by: - The number and proportion of reported contacts who received SARS-CoV-2 testing. - The number and proportion of contacts who are successfully reached by phone by MOH district contact tracing unit. - The number and proportion of contacts testing positive for SARS-CoV-2 infection. - The time from SARS-CoV-2 infected index patient identification of contacts to communication with the contact by the district contact tracing unit. 2. Secondary objectives: - To assess the feasibility and acceptability of the use of the Mamal Pro digital contact tracing module through structured interviews with MOH facility staff, district unit contract tracing teams, and individuals undergoing SARS-CoV-2 testing. - To estimate the total cost of using the Mamal Pro contact tracing module for tracing SARS-CoV2 positive case contacts and cost per contact traced using the module.


Recruitment information / eligibility

Status Completed
Enrollment 433
Est. completion date July 30, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All contacts listed by individuals registered in the Mamal Pro app for testing, who test positive for SARS-CoV-2 in the selected health district testing units and health facilities in Cameroon. Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Digital based contact tracing
Listing of contacts by SARS-CoV-2 positive individuals in Mamal Pro app + verification and validation by a health care worker. Immediate access to the contact list in Mamal Pro once validated by the health care worker. Contacts are immediately notified by text message automatically sent to all contacts with phone numbers and later called by the HCWs responsible for carrying out the contact tracing at the district level. Contacts will be invited to go to the nearest testing facilities/units to get tested. Those who are unable or refuse to come for testing are followed up by phone for 10 days for the occurrence of COVID-19 symptoms. Information about the contact tracing process during communication with contacts are recorded in Mamal Pro digital contact tracing module.

Locations

Country Name City State
Cameroon Bonanjo Integrated Health Center Douala Littoral
Cameroon Bonassama District COVID testing unit Douala Littoral
Cameroon Bonassama district hospital Douala Littoral
Cameroon Cité des palmiers District COVID testing unit Douala Littoral
Cameroon Cité des palmiers district hospital Douala Littoral
Cameroon CMA Bonamoussadi Douala Littoral
Cameroon CMA Nyala Douala Littoral
Cameroon CMA Soboum hospital Douala Littoral
Cameroon Deido District COVID testing unit Douala Littoral
Cameroon Deido district hospital Douala Littoral
Cameroon General Hospital Douala Douala Littoral
Cameroon Gynecological-Obstetric and Pediatric Hospital Douala (HGOPED) Douala Littoral
Cameroon Japoma District COVID testing unit Douala Littoral
Cameroon Laquintinie Hospital Douala Littoral
Cameroon Logbaba District COVID testing unit Douala Littoral
Cameroon Logbaba district hospital Douala Littoral
Cameroon Mbangue District COVID testing unit Douala Littoral
Cameroon Mboppi Baptist hospital Douala Littoral
Cameroon New Bell District COVID testing unit Douala Littoral
Cameroon New Bell district hospital Douala Littoral
Cameroon Nylon District COVID testing unit Douala Littoral
Cameroon Nylon district hospital Douala Littoral

Sponsors (3)

Lead Sponsor Collaborator
Elizabeth Glaser Pediatric AIDS Foundation Cameroon Ministry of Public Health, Find

Country where clinical trial is conducted

Cameroon, 

Outcome

Type Measure Description Time frame Safety issue
Primary Successful contact tracing The primary outcome is the proportion of contacts declared by the index case who are successfully called by the district contact tracing unit and the proportion of contacts who receive SARS-CoV-2 testing, as per MOH standard testing procedures. 10 days
Secondary Contacts testing positive for SARS-CoV-2 infection. The proportion of contacts testing positive for SARS-CoV2 infection 10 days
Secondary Feasibility of the intervention model of contact tracing ease of use
time to complete the process in the Mamal Pro digital contact tracing module
integration with other clinic activities
4 months
Secondary Acceptability intervention model of contact tracing by the index cases (negative and positive) and health care workers satisfaction of using the Mamal Pro digital contact tracing module compared with the usual standard of care approach
challenges with this approach to contact tracing
suggestions for improvement.
4 months
Secondary Cost of the intervention Cost estimates for using Mamal Pro digital contact tracing module to trace contacts, and cost per contact traced. 4 months
Secondary Timely communication with contacts Time (days) between receipt of contact list and contacts' call attempts 4 months
Secondary SMS sent Proportion of SMS delivered, (numerator: SMS sent, denominator: phone numbers) 4 months
See also
  Status Clinical Trial Phase
Recruiting NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Active, not recruiting NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure